Gross Profit On Sales Veränderung Datum
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
Agios Pharmaceuticals USD 6.52M 249K 2023-12
Akebia Therapeutics USD 45.68M 13.5M 2023-12
Almirall EUR 359.69M 23.71M 2023-06
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
Amarin USD 42.5M 14.47M 2023-09
Ardelyx USD 48.7M 29.85M 2023-09
Astellas Pharma JPY 317.74B 11.69B 2023-09
AstraZeneca USD 9.43B 15M 2023-09
Bluebird Bio USD 1.44M 4.11M 2023-09
Charles River Laboratories USD 370.75M 5.32M 2023-12
Esperion Therapeutics USD 20.59M 1.59M 2023-09
Exact Sciences USD 475.02M 15.21M 2023-12
Halozyme Therapeutics USD 177.74M 16.53M 2023-12
Incyte USD 949.29M 84.66M 2023-12
Ironwood Pharmaceuticals USD 117.13M 13.38M 2021-12
Lexicon Pharmaceuticals USD 155K 154K 2023-09
Moderna USD 1.88B 2.29B 2023-12
Myriad Genetics USD 135M 700K 2023-12
Pacira USD 133.55M 9.38M 2023-12
PTC Therapeutics USD 277.94M 90.85M 2023-12
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
Takeda JPY 699.51B 38B 2023-09
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12
Vanda Pharmaceuticals USD 42.56M 15.17M 2023-06



Ironwood Pharmaceuticals Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.